LA
MRNA icon

LBP AM’s Moderna MRNA Stock Holding History

LBP AM’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-184,606
Closed -$7.68M – 376
2024
Q4 		$7.68M Buy
184,606
+180,714
+4,643% +$8.64M 0.1% 157
2024
Q3 		$260K Buy
+3,892
New +$357K ﹤0.01% 349
2023
Q4 		– Sell
-5,516
Closed -$570K – 462
2023
Q3 		$570K Sell
5,516
-1,835
-25% -$205K 0.01% 402
2023
Q2 		$893K Sell
7,351
-167
-2% -$22.3K 0.02% 344
2023
Q1 		$1.15M Sell
7,518
-533
-7% -$87.9K 0.03% 348
2022
Q4 		$1.45M Buy
+8,051
New +$1.32M 0.04% 310

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

LBP AM's MRNA Position: Q1 2025 in Review

LBP AM sold out of Moderna (MRNA) in Q1 2025, closing a stake of 184,606 shares — an estimated $7.68M sold.

LBP AM first reported a position in MRNA in Q4 2022 and held it in 6 quarters. The position peaked at $7.68M in Q4 2024. 693 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • LBP AM reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
  • LBP AM sold 184,606 Moderna shares in Q1 2025, an estimated $7.68M.
  • LBP AM first reported a position in Moderna in Q4 2022 and held it in 6 quarters.
  • LBP AM's Moderna position peaked at $7.68M in Q4 2024.
  • 693 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on LBP AM's 13F filing for Q1 2025, filed 30 Apr 2025.